Zainab Shinkafi-Bagudu: Introducing the Patient Access to Care program
Zainab Shinkafi-Bagudu shared a post on LinkedIn:
“Introducing the Patient Access to Care (PACE) program—an important initiative in my commitment as a cancer advocate to ensure patient access to treatment and care.
Built on the success of the 2019 One Call Away project, PACE provides affordable access to a wide range of cancer treatments, including chemotherapy, radiotherapy, diagnostics, surgical interventions and support.
By partnering with pharmaceutical companies, we aim to bridge the gap in cancer care, particularly for underprivileged patients.
Despite the challenges, PACE is dedicated to improving the quality of life for all cancer patients through comprehensive support and care. In the last 5 years, PACE has supported 150 patients in chemotherapy and drug payments, assisted 3720 patients in screening and recorded over $43,000 in subsidy for its beneficiaries.
Let’s stand united in the fight against cancer. Support the PACE program today and help us provide life-saving treatments to those who need them most. Your contribution can bring hope and healing to countless lives—get involved now.
To Support Contact: 07088744634
Email: [email protected].”
Proceed to the video attached to the post.
Source: Zainab Shinkafi-Bagudu/LinkedIn
Dr. Zainab Shinkafi-Bagudu is a global cancer advocate, a pediatrician, a UICC Board Member, Founder of the Medicaid Cancer Foundation, and the Chairperson of First Ladies Against Cancer (FLAC).
Dr. Bagudu is working with the state ministries of health, education, and women affairs to implement programs to sustainably improve menstrual hygiene, girl-child education, economic empowerment of women, and put an end to gender-based violence. Zainab Shinkafi-Bagudu is a member of the Editorial Board of OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023